Yahoo
NasdaqCM - Nasdaq Real Time Price USD

aTyr Pharma, Inc. (ATYR)

0.4808 -0.0165 (-3.32%)
At close: September 8 at 4:00:01 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
190
190
235
353
10,386
Operating Expense
64,048
77,817
68,149
55,272
56,790
Operating Income
-63,858
-77,627
-67,914
-54,919
-46,404
Other Income Expense
3,046
3,504
3,892
4,522
1,061
Pretax Income
-60,812
-74,123
-64,022
-50,397
-45,343
Net Income Common Stockholders
-60,807
-74,118
-64,023
-50,389
-45,338
Diluted NI Available to Com Stockholders
-60,807
-74,118
-64,023
-50,389
-45,338
Basic EPS
-0.63
-0.80
-0.86
-0.94
-1.60
Diluted EPS
-0.63
-0.80
-0.86
-0.94
-1.60
Basic Average Shares
97,857.4720
92,985.3590
74,261.2650
53,606.4880
28,419.5690
Diluted Average Shares
97,857.4720
92,985.3590
74,261.2650
53,606.4880
28,419.5690
Total Operating Income as Reported
-63,858
-77,627
-67,914
-54,919
-46,404
Total Expenses
64,048
77,817
68,149
55,272
56,790
Net Income from Continuing & Discontinued Operation
-60,807
-74,118
-64,023
-50,389
-45,338
Normalized Income
-60,807
-74,118
-64,023
-50,389
-45,338
EBIT
-63,858
-77,627
-67,914
-54,919
-46,404
EBITDA
-62,276
-76,074
-66,374
-52,178
-44,709
Reconciled Depreciation
1,582
1,553
1,540
2,741
1,695
Net Income from Continuing Operation Net Minority Interest
-60,807
-74,118
-64,023
-50,389
-45,338
Normalized EBITDA
-62,276
-76,074
-66,374
-52,178
-44,709
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 5/7/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: